Technologies

Medical Sciences

Title:	Synthesis of Cetyl Myristoleate (CMO) Isomers for the Treatment of Osteoarthritis and Other Joint Inflammatory Diseases
Area:	Medical Sciences
Focus Area:	Treatment of Osteoarthritis
Patent:	CN102348482, EP2379175, US8816109
Social Benefits:	The process involves : Preparation of Myristoleic acid from oleic/undecenoic acid , Transesterification of Myristoleic acid with cetyl alcohol to obtain cetyl myristoleate isomers
Developing Agency:	CSIR-Indian Institute of Chemical Technology (IICT), Telangana
Technology Readiness Index:	Lab Validation
Email:	director@iict.res.in
Website Link :	http://www.iictindia.org
Source (more info) :	https://t.ly/l_sb

Brief Description

Description :

Cetyl myristoleate (CMO) is the common name for hexadecyl cis-9- myristoleate. CMO is well known for its anti-arthritis properties. The main component of CMO is cis-9 myristoleic acid, and is being isolated from selective natural sources along with other fatty acids. CMO is being sold in the market for the treatment of different forms of arthritis, osteoarthritis, as well as many other forms of diseases.